Literature DB >> 16644920

Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis.

Ken Goto1, Sarah N Salm, Sandra Coetzee, Xiaozhong Xiong, Patricia E Burger, Ellen Shapiro, Herbert Lepor, David Moscatelli, E Lynette Wilson.   

Abstract

Prostate carcinoma and benign prostatic hypertrophy may both originate in stem cells, highlighting the importance of the characterization of these cells. The prostate gland contains a network of ducts each of which consists of a proximal (adjacent to the urethra), an intermediate, and a distal region. Here, we report that two populations of cells capable of regenerating prostatic tissue in an in vivo prostate reconstitution assay are present in different regions of prostatic ducts. The first population (with considerable growth potential) resides in the proximal region of ducts and in the urethra, and the survival of these cells does not require the presence of androgens. The second population (with more limited growth potential) is found in the remaining ductal regions and requires androgen for survival. In addition, we find that primitive proximal prostate cells that are able to regenerate functional prostatic tissue in vivo are also programmed to re-establish a proximal-distal ductal axis. Similar to their localization in the intact prostate, cells with the highest regenerative capacity are found in the proximal region of prostatic ducts formed in an in vivo prostate reconstitution assay. The primitive proximal cells can be passaged through four generations of subrenal capsule grafts. Together, these novel findings illustrate features of primitive prostate cells that may have implications for the development of therapies for treating proliferative prostatic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644920     DOI: 10.1634/stemcells.2005-0585

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  48 in total

1.  Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia.

Authors:  Tristan M Nicholson; Kristen S Uchtmann; Conrad D Valdez; Ashleigh B Theberge; Tihomir Miralem; William A Ricke
Journal:  J Vis Exp       Date:  2013-08-28       Impact factor: 1.355

Review 2.  Stem cells in prostate cancer initiation and progression.

Authors:  Devon A Lawson; Owen N Witte
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Isolation and functional characterization of murine prostate stem cells.

Authors:  Devon A Lawson; Li Xin; Rita U Lukacs; Donghui Cheng; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

4.  Anchorage-independent culture maintains prostate stem cells.

Authors:  Xudong Shi; Jerry Gipp; Wade Bushman
Journal:  Dev Biol       Date:  2007-09-29       Impact factor: 3.582

5.  Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells.

Authors:  Bobby Bhatia; Ming Jiang; Mahipal Suraneni; Lubna Patrawala; Mark Badeaux; Robin Schneider-Broussard; Asha S Multani; Collene R Jeter; Tammy Calhoun-Davis; Limei Hu; Jianhua Hu; Spiridon Tsavachidis; Wei Zhang; Sandy Chang; Simon W Hayward; Dean G Tang
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

Review 6.  Mesenchymal stem cells and the embryonic reawakening theory of BPH.

Authors:  W Nathaniel Brennen; John T Isaacs
Journal:  Nat Rev Urol       Date:  2018-11       Impact factor: 14.432

7.  Endothelial cells support the growth of prostate tissue in vivo.

Authors:  Michael Bates; Bruce Kovalenko; E Lynette Wilson; David Moscatelli
Journal:  Prostate       Date:  2008-06-01       Impact factor: 4.104

8.  Axin2 expression identifies progenitor cells in the murine prostate.

Authors:  Christopher S Ontiveros; Sarah N Salm; E Lynette Wilson
Journal:  Prostate       Date:  2008-09-01       Impact factor: 4.104

Review 9.  Prostate stem cells and benign prostatic hyperplasia.

Authors:  John T Isaacs
Journal:  Prostate       Date:  2008-06-15       Impact factor: 4.104

10.  Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate.

Authors:  Alison K Esser; Michael B Cohen; Michael D Henry
Journal:  Prostate       Date:  2010-05-15       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.